Healthtech Startups

ARIA develops a head-worn assistive device for blind and vision-impaired users, combining augmented reality audio, novel control interfaces, and AI-powered sensor systems. The company is led by blind subject matter experts and is pursuing regulatory approval as a Class 2a TGA and FDA Class 1 device.

1 investor

Aridhia develops the Digital Research Environment (DRE), a trusted research platform for biomedical and health informatics that enables researchers across multiple countries to collaborate on health research and data-intensive health delivery programs. The platform addresses regulatory compliance, data management, and collaboration challenges in scaling health research initiatives.

1 investor

ARION develops biomechanical footwear and movement analysis technology that decodes human motion patterns to optimize shoe design and performance. The company serves athletes and consumers seeking footwear tailored to individual movement profiles.

1 investor

Arion Care (美中爱瑞) is an oncology-focused hospital in China providing cancer diagnosis and treatment through multidisciplinary team (MDT) consultations and specialized centers for lung, breast, gastrointestinal, gynecologic, urologic, hepatobiliary, lymphoma, neurologic, and other cancers. It offers services such as case managers, radiotherapy, precision health medicine, cancer rehabilitation, and commercial insurance direct billing for patients.

1 investor

Arithmedics builds an AI-powered platform for healthcare administration that handles medical billing, coding, and revenue cycle management for medical practices. The system works alongside physicians during documentation to flag gaps, generate CPT/ICD-10 codes, and enter them into existing EHR systems to reduce denials and after-hours paperwork.

1 investor

Seattle 'scientific wellness' startup that paired genetic, blood and microbiome testing with health coaching; closed in 2019.

1 investor

AZ Nutritional is a contract manufacturer of dietary supplements, offering sourcing, formulation, and lab testing services to supplement brands. It positions itself as a manufacturing partner focused on product quality, potency, and third-party verification.

1 investor

Ark Surgical develops tissue containment systems for minimally invasive gynecological procedures. The company's flagship product is designed to enable safe surgical outcomes in women's health by reducing reliance on open abdominal surgery.

1 investor

Arksense is building a monitoring and intelligence platform for people managing chronic disease.

1 investor

Arkstone develops AI-powered clinical decision support tools to guide healthcare providers in appropriate antibiotic prescribing and antimicrobial stewardship, reducing unnecessary antibiotic use and antimicrobial resistance. The company serves laboratory professionals, infectious disease specialists, and healthcare systems worldwide.

1 investor

Arlo offers health benefit plans for small and mid-sized employers (teams of 5-250 employees), featuring up-front pricing, $0 primary-care copays, covered preventive screenings, and concierge support. It also provides brokers with instant quotes, plan analytics, and renewal tools, with coverage available across most U.S. states.

1 investor

Arlo provides on-demand healthcare access through an AI agent that connects users to providers for consultations, prescriptions, labs, and referrals, integrating personal health data (such as WHOOP sleep and stress metrics) into the clinical process. It offers same-day prescription delivery and order handling via text for consumers.

1 investor

Arlyn builds an intelligence layer that makes the fragmented U.S. drug access ecosystem machine-readable, mapping plans, employers, TPAs, PBMs, GPOs, formularies, and utilization rules across millions of records. It serves life sciences and drug innovators, helping them identify access barriers and measure whether access investment leads to patient impact.

1 investor

ArmasTec develops fabric exoskeletons for workers across industrial, hospitality, and healthcare sectors. The company aims to make wearable exoskeleton technology widely accessible for manual work across diverse industries.

1 investor

ARMGO develops a novel class of therapeutics called Rycals that target ryanodine receptors (RyRs) to correct calcium channel dysfunction in serious diseases with high unmet need. Its lead candidate, Surlorian, is being developed for heart failure by addressing an underlying driver of disease progression.

1 investor

ARMR Sciences is developing conjugate vaccines and biologic countermeasures, including its lead candidate ARMR-100, designed to bind fentanyl in the bloodstream and prevent overdose from synthetic drugs. It targets high-risk populations such as first responders, military personnel, and individuals in recovery, working on a platform approach to address emerging drug threats.</parameter> <parameter name="sector_codes">["biotech", "healthtech", "deeptech"]

1 investor

ARNA Genomics US develops liquid biopsy multiomics diagnostic technologies, with a current focus on ARNA Breast, an assay for early-stage breast cancer detection. The company operates as a research diagnostic laboratory conducting clinical trials on its cancer marker tests.

1 investor

Aroa Biosurgery Limited manufactures medical devices, including Endoform, for surgical applications with coverage under Medicare reimbursement policies.

1 investor

Arōe provides personalized, science-based preventative care and longevity services including nutrient IV therapy, personalized treatment plans, and lifestyle interventions for health optimization. The company serves individuals seeking proactive health management through in-person clinic visits and concierge services delivered to home or office locations.

1 investor

Arogya Finance provides medical loans to underserved populations in India using alternative risk assessment tools to finance patients outside the formal banking system. The company operates as a non-bank financial company serving individuals seeking treatment at hospitals of their choice.

1 investor

AROMICS develops functional genomics and proteomics technologies for research and development of new therapies and diagnostic products in human health. The company focuses on translational research, personalized medicine, and biomarker identification for the pharmaceutical and diagnostics industries.

1 investor

Aronora is a clinical-stage biotech developing antithrombotic therapies, including factor XI/XIa inhibitors and thrombolytic drug candidates, to treat and manage thrombotic and thromboembolic conditions such as acute ischemic stroke, heart attack, and pulmonary embolism. Its pipeline of cardio-hematology programs targets patients requiring time-sensitive thrombolytic intervention or management of thrombosis risk.

1 investor

Advanced Reconstructive Surgery Alliance (ARSA) is a physician practice management organization (MSO) that provides business support—including compliance, credentialing, finance, HR, IT, marketing, M&A, revenue cycle management, and research—to reconstructive and cosmetic surgery practices. It operates a national network of more than 80 physicians across multiple U.S. states under a "PrivAdemic" model combining private practice with academic collaboration.

1 investor

Arseus Medical Group distributes medical and paramedical products, devices, and aids, ranging from single-use consumables to capital equipment, and provides related sales, marketing, and technical support services. It serves healthcare specialists, generalists, and care service providers.

1 investor